Logo image of OBIO

ORCHESTRA BIOMED HOLDINGS IN (OBIO) Stock Earnings Estimates

USA - Nasdaq - NASDAQ:OBIO - US68572M1062 - Common Stock

4.04 USD
-0.09 (-2.18%)
Last: 1/23/2026, 8:25:44 PM
4.04 USD
0 (0%)
After Hours: 1/23/2026, 8:25:44 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
OBIO revenue by date.OBIO revenue by date.
3.53M
552.56%
2.76M
-21.81%
2.638M
-4.42%
3.605M
36.66%
3.688M
2.30%
2.809M
-23.83%
23.231M
727.02%
54.718M
135.54%
113.54M
107.50%
146.52M
29.05%
200.12M
36.58%
251.02M
25.43%
EBITDA
YoY % growth
OBIO ebitda by date.OBIO ebitda by date.
-32.44M
-50.05%
-51.219M
-57.89%
-63.993M
-24.94%
-75.888M
-18.59%
-80.376M
-5.91%
-74.868M
6.85%
-78.744M
-5.18%
-48.552M
38.34%
1.938M
103.99%
44.88M
2,215.79%
81.702M
82.05%
113.12M
38.45%
EBIT
YoY % growth
OBIO ebit by date.OBIO ebit by date.
-32.66M
-49.82%
-51.506M
-57.70%
-64.301M
-24.84%
-80.228M
-24.77%
-88.909M
-10.82%
-80.164M
9.84%
-57.446M
28.34%
-22.811M
60.29%
33.136M
245.27%
66.147M
99.62%
117.71M
77.95%
166.36M
41.33%
Operating Margin
OBIO operating margin by date.OBIO operating margin by date.
-925.21%-1,866.16%-2,437.49%-2,225.47%-2,410.76%-2,853.83%-247.28%-41.69%29.18%45.15%58.82%66.27%
EPS
YoY % growth
OBIO eps by date.OBIO eps by date.
N/A-1.50
84.66%
-1.66
-10.67%
-1.78
-7.43%
-1.63
8.70%
-1.30
20.42%
-0.66
49.22%
-0.19
70.54%
0.41
314.05%
0.45
8.19%
0.83
84.09%
1.16
40.74%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth
-0.39
8.06%
-0.42
13.40%
-0.41
18.81%
-0.40
1.06%
-0.39
-0.91%
Revenue
Q2Q % growth
943.204K
272.81%
887.604K
2.26%
899.436K
7.59%
894.948K
3.94%
911.268K
-3.39%
EBITDA
Q2Q % growth
-19.346M
-18.19%
-22.848M
-21.29%
-21.318M
-11.25%
-21.114M
-5.21%
-20.91M
-8.08%
EBIT
Q2Q % growth
-20.578M
-23.39%
-22.8M
-20.50%
-22.127M
-14.49%
-21.765M
-7.15%
-21.565M
-4.79%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
-0.40
2.44%
-0.440.049.82%
Q2 2025
Q2Q % growth
-0.50
-11.11%
-0.510.012.68%
Q1 2025
Q2Q % growth
-0.49
-28.95%
-0.490.000.13%
Q4 2024
Q2Q % growth
-0.42
-13.51%
-0.440.023.57%
Q3 2024
Q2Q % growth
-0.41
-7.89%
-0.440.036.52%
Q2 2024
Q2Q % growth
-0.45
-28.57%
-0.40-0.05-12.33%
Q1 2024
Q2Q % growth
-0.38
5.00%
-0.410.036.39%
Q4 2023
Q2Q % growth
-0.37
78.79%
-0.380.013.65%
Q3 2023
Q2Q % growth
-0.38 -0.400.024.47%
Q2 2023
Q2Q % growth
-0.35 -0.420.0717.32%
Q1 2023
Q2Q % growth
-0.40 -0.29-0.11-37.60%
OBIO Yearly EPS VS EstimatesOBIO Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 -2 -4 -6 -8
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
861K
-12.77%
772.752K88.248K11.42%
Q2 2025
Q2Q % growth
836K
7.46%
709.512K126.488K17.83%
Q1 2025
Q2Q % growth
868K
40.00%
537.03K330.97K61.63%
Q4 2024
Q2Q % growth
253K
-3.44%
857.993K-604.993K-70.51%
Q3 2024
Q2Q % growth
987K
135.56%
725.73K261.27K36.00%
Q2 2024
Q2Q % growth
778K
-14.97%
870.57K-92.57K-10.63%
Q1 2024
Q2Q % growth
620K
-46.74%
955.403K-335.403K-35.11%
Q4 2023
Q2Q % growth
262K
-76.18%
1.014M-752K-74.16%
Q3 2023
Q2Q % growth
419K
-63.88%
912.9K-493.9K-54.10%
Q2 2023
Q2Q % growth
915K
128.75%
720.12K194.88K27.06%
Q1 2023
Q2Q % growth
1.164M
33.79%
693.6K470.4K67.82%
Q4 2022
Q2Q % growth
1.1M
144.90%
1.204M-104K-8.64%
Q3 2022
Q2Q % growth
1.16M
-12.78%
%
Q2 2022
Q2Q % growth
400K
140.82%
%
Q1 2022
Q2Q % growth
870K
-34.09%
%
OBIO Yearly Revenue VS EstimatesOBIO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 50M 100M 150M 200M 250M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0.33% 13.14% 0.21% 4.82%
Revenue5.22% 8.1% 0.67% 5.72%